Akio Imanishi Selected Research

Fatigue

9/2005

[Clinical biochemical evaluation of central fatigue with 24-hour continuous exercise].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akio Imanishi Research Topics

Disease

2	Hypersensitivity (Allergy) 01/2012 - 01/2012
1	Thrombocytopenia (Thrombopenia) 06/2023
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2019
1	Peptic Ulcer (Peptic Ulcers) 05/2012
1	Gastroesophageal Reflux (GERD) 05/2012
1	Constipation 01/2012
1	Fatigue 09/2005

Drug/Important Bio-Agent (IBA)

2	Serotonin (5 Hydroxytryptamine)IBA 01/2012 - 09/2005
1	PolymersIBA 06/2023
1	Blood Proteins (Serum Proteins)IBA 06/2023
1	CholesterolIBA 06/2023
1	OligonucleotidesIBA 06/2023
1	Nucleic AcidsIBA 06/2023
1	Antisense OligonucleotidesIBA 06/2023
1	Voltage-Gated Sodium ChannelsIBA 01/2019
1	ParvalbuminsIBA 01/2019
1	FumaratesIBA 05/2012
1	AcidsIBA 05/2012
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 05/2012
1	ricinoleic acid (ricinelaidic acid)IBA 01/2012
1	Analgesics (Analgesic Drugs)IBA 01/2012
1	alosetron (Lotronex)FDA Link 01/2012
1	4- (difluoromethoxy)- N- (2- ((4- (methoxymethyl)- 2,3,3a,4,5,9b- hexahydro- 1H- pyrrolo(3,2- c)quinolin- 1- yl)carbonyl)cyclohexyl)benzamideIBA 01/2012
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2012
1	ZymosanIBA 01/2012
1	TachykininsIBA 01/2012
1	Factor V (Coagulation Factor V)IBA 09/2005

Therapy/Procedure

1	Therapeutics 06/2023